Vir Biotechnology (VIR) Gross Margin Growth (1y) (2021 - 2025)

Vir Biotechnology (VIR) Gross Margin Growth (1y) (2021 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (1y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 372.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -5.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -165.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 236.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Vir Biotechnology 1.38 Bn 1.38 Bn - -

Historic Data

Download Data
DateValue
Jun 30, 2025 78.00
Mar 31, 2025 11.00
Dec 31, 2024 -77.00
Sep 30, 2024 -66.00
Jun 30, 2024 -111.00
Mar 31, 2024 291.00
Dec 31, 2023 738.00
Sep 30, 2023 450.00
Jun 30, 2023 6,814.00
Mar 31, 2023 429.00
Dec 31, 2022 -514.00
Sep 30, 2022 162.00
Jun 30, 2022 -6,804.00
Mar 31, 2022 -731.00
Dec 31, 2021 -700.00
Sep 30, 2021 -756.00
Jun 30, 2021 -68.00